Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Sep. 30, 2015	$ 1,540,117	$ 107,392	$ 17,154,945	$ (15,722,220)
Beginning balance (in shares) at Sep. 30, 2015		107,392,205
Net loss	(5,992,370)			(5,992,370)
Issuance of restricted stock for services	52,500	$ 150	52,350
Issuance of restricted stock for services (in shares)		150,000
Shares issued for the exercise of warrants	2,708,749	$ 11,845	2,696,904
Shares issued for the exercise of warrants (in shares)		11,844,516
Shares issued for the exercise of stock options	0	$ 69	(69)
Shares issued for the exercise of stock options (in shares)		68,967
Exercise of Series A Warrants Cashless	0	$ 2,334	(2,334)
Exercise of Series A Warrants Cashless (in shares)		2,333,559
Issuance of common stock in private placement funding	3,108,939	$ 9,418	3,099,521
Issuance of common stock in private placement funding (in shares)		9,418,334
Shares issued for the conversion of the convertible notes	644,900	$ 3,224	641,676
Shares issued for the conversion of the convertible notes (in shares)		3,224,494
Stock based compensation expense	1,098,160		1,098,160
Ending balance at Sep. 30, 2016	3,160,995	$ 134,432	24,741,153	(21,714,590)
Ending balance (in shares) at Sep. 30, 2016		134,432,075
Net loss	(7,788,856)	$ 0	0	(7,788,856)
Issuance of restricted stock for services	162,000	$ 225	161,775	0
Issuance of restricted stock for services (in shares)		225,000
Shares issued for the exercise of warrants	1,589,888	$ 4,979	1,584,909	0
Shares issued for the exercise of warrants (in shares)		4,978,742
Shares issued for the exercise of stock options	5,500	$ 15	5,485	0
Shares issued for the exercise of stock options (in shares)		15,000
Shares issued for the exercise of stock options - Cashless	$ 0	$ 106	(106)	0
Shares issued for the exercise of stock options - Cashless (in shares)		106,666
Shares issued for the exercise of stock options (in shares)	255,000
Exercise of Series A Warrants Cashless	$ 0	$ 19	(19)	0
Exercise of Series A Warrants Cashless (in shares)		18,710
Issuance of common stock in private placement funding	2,991,012	$ 10,167	2,980,845	0
Issuance of common stock in private placement funding (in shares)		10,166,664
Stock based compensation expense	2,105,980	$ 0	2,105,980	0
Ending balance at Sep. 30, 2017	$ 2,226,519	$ 149,943	$ 31,580,022	$ (29,503,446)
Ending balance (in shares) at Sep. 30, 2017		149,942,857